Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Ranibizumab for Neovascular Age-Related Macular Degeneration
5.793
Zitationen
7
Autoren
2006
Jahr
Abstract
Intravitreal administration of ranibizumab for 2 years prevented vision loss and improved mean visual acuity, with low rates of serious adverse events, in patients with minimally classic or occult (with no classic lesions) choroidal neovascularization secondary to age-related macular degeneration. (ClinicalTrials.gov number, NCT00056836 [ClinicalTrials.gov].).
Ähnliche Arbeiten
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
1993 · 24.577 Zit.
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 · 16.333 Zit.
The biology of VEGF and its receptors
2003 · 9.499 Zit.
The number of people with glaucoma worldwide in 2010 and 2020
2006 · 7.309 Zit.
Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs
2016 · 7.203 Zit.